I do not expect for this projection to be unlimited in its extention in timeframes.
Once US based biotech banks and investors side with us, which is currently prepared, price will snap up the gap you mentioned.
This reinforces the need to be positioned prior to this event/s.
Market treats the stock as if the US funding story has no legs.
Quite short sighted but to be expected. A catch up event will then follow once
domestic market realises the dimensions of the US funding arrangements.
Not the first I observe this lag of the ASX to understand US biotech dynamics.
So it is strangely familiar to see this unfold here yet again in the same fashion.
What it allows investors like myself is to accumulate within an ignorant market.
all IMO
PYC Price at posting:
15.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)